Athersys, Inc. (ATHX) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
jrdelane jrdelane 05/10/2016 3 months $2.31 $2.50 +8.24% 8 Ended
Comments: Their IS trial will succeed in Japan and they will expand partnership with Healios.
mcdonowil mcdonowil 03/22/2016 1 Year $2.44 $1.16 -52.46% -52 Ended
Comments: Poised to announce a USA partner
RichardSanchez RichardSanchez 01/15/2016 3 months $1.16 $2.37 +104.31% 104 Ended
HomeBrewer HomeBrewer 03/23/2015 3 months $3.27 $1.20 -63.3% -63 Ended
Comments: The sector is growing and this company seems to be well managed
siriusblack siriusblack 03/05/2015 3 months $2.93 $1.31 -55.29% -55 Ended
Harmeet Harmeet 01/09/2014 3 months $4.07 $3.00 -26.29% -26 Ended
Comments: Progressing positively on its clinical trials
zargboss zargboss 12/23/2013 3 months $2.17 $3.39 +56.22% 56 Ended
Comments: Has potential to be a great growth opportunity. Passed stage 2 with Pfizer with great results.
tambor tambor 11/28/2013 1 month $2.03 $2.43 +19.7% 19 Ended
robertg5533 robertg5533 05/10/2013 3 months $1.99 $1.80 -9.73% -9 Ended
Comments: the leadership,product,institutional investors seem so confident!!!!!!
constantine constantine 01/21/2011 3 months $2.78 $1.57 -43.53% -43 Ended
Comments: Industry sector growing or poised for growth
Buffetson Buffetson 01/05/2010 3 months N/A Ended
Comments: This stock will go to around 20$ !!!

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.